Inizio

Inizio is a scaled commercialization platform that unlocks, activates and optimizes value for pharma and biopharma at each pivotal moment. ​ We apply our collective expertise to our clients’ most complex challenges, helping them make the right strategic choices to unlock the full value of their healthcare innovation – so more people get the medicines they need, faster. ​ With over 11,700 empowered experts across 50 countries, we continue to achieve meaningful results: ​ 📈 100% of top 20 pharma as clients (based on worldwide sales) ​ 📈 328 products where we have supported in early-stage pre-commercialization (2021-2022) ​ 📈 50% of all US product launches supported (2021-2022) ​ 📈 95% of top products supported in 2022 (by revenue generation) ​ To find out more about Inizio, visit our website below.